BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2176674)

  • 1. Cytopathogenicity, drug susceptibility, and thymidine kinase activity of a retinovirulent herpes simplex virus type 2.
    Langford MP; Colacino JM; Kaiwar R; Mahjoub SB; Ganley JP
    J Med Virol; 1990 Aug; 31(4):301-5. PubMed ID: 2176674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thymidine kinase activities indiced in cells productively infected with herpesvirus saimiri and herpes simplex virus.
    Honess RW; O'Hare P; Young D
    J Gen Virol; 1982 Feb; 58(Pt 2):237-49. PubMed ID: 6278057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
    Balzarini J; Bohman C; De Clercq E
    J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of nucleoside analogs by equine herpesvirus type 1 pyrimidine deoxyribonucleoside kinase.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Jan; 7(1):53-67. PubMed ID: 3026247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acyclovir and presence of cellular and viral thymidine kinase activity in herpes simplex virus infected cells. Brief report.
    Harmenberg J; Källander CF; Gronowitz JS
    Arch Virol; 1982; 74(2-3):219-25. PubMed ID: 6299236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyclovir resistance in herpes simplex virus type 1: biochemical and functional studies on the thymidine kinase of the highly resistant R100 strain.
    Palú G; Bevilacqua F; Biasolo MA; Parolin C; Tognon M; Romanelli MG; Meloni GA
    Virus Res; 1989 Aug; 13(4):303-18. PubMed ID: 2554611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of [125I]iododeoxycytidine by cells infected with herpes simplex virus: a rapid screening test for resistance to acyclovir.
    Van Dyke RB; Connor JD
    J Infect Dis; 1985 Dec; 152(6):1206-11. PubMed ID: 2999258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbocyclic 5-iodo-2'-deoxyuridine (C-IDU) and carbocyclic (E)-5-(2-bromovinyl)-2'-deoxyuridine (C-BVDU) as unique examples of chiral molecules where the two enantiomeric forms are biologically active: interaction of the (+)- and (-)-enantiomers of C-IDU and C-BVDU with the thymidine kinase of herpes simplex virus type 1.
    Balzarini J; De Clercq E; Baumgartner H; Bodenteich M; Griengl H
    Mol Pharmacol; 1990 Mar; 37(3):395-401. PubMed ID: 2156153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir.
    Kit S; Sheppard M; Ichimura H; Nusinoff-Lehrman S; Ellis MN; Fyfe JA; Otsuka H
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1483-90. PubMed ID: 2829709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
    Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acyclovir, oxetanocin-G, and carbocyclic oxetanocin-G in combinations on the replications of herpes simplex virus type 1 and type 2 in Vero cells.
    Saijo M; Suzutani T; Yoshida I
    Tohoku J Exp Med; 1992 May; 167(1):57-68. PubMed ID: 1333651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
    Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
    Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine on the proliferation of herpes simplex virus type 1-transformed and thymidine kinase-deficient mouse cells.
    Bubley G; Crumpacker C; De Clercq E; Schnipper L
    Virology; 1983 Sep; 129(2):490-2. PubMed ID: 6312685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.